Treatment of precancerous cervical lesions by thermo coagulation at the Aminata Souaré screening center of the Medisar polyclinic

Abstract

Objective:The objective was to contribute to the improvement of the management of precancerous cervical lesions by thermocoagulation at the Aminata Souaré screening center of the Médisar polyclinic.

Material and Methods: This was a retrospective cohort of 6 months duration from October 2019 to March 2020, involving all women aged 20 to 65 years admitted for cervical cancer screening, presenting precancerous lesions and treated by thermocoagulation at the Aminata Souaré screening center.

Results: During the study period, 1616 women were screened for cervical cancer, of whom 82 (5%) had precancerous lesions, of which 42 (51.21%) were treated by thermocaogulation. The mean age was 39.57 ± 12.43 years with extremes of 20 and 64 years. The squamocolumnar junction was visible in all patients (100%). Visual inspection with acetic acid and Lugol's iodine showed acetowhite and iodine-negative areas respectively in all cases (100%). Colposcopy was performed in all patients, demonstrating isolated precancerous lesions in 41 (97.6%) cases. Diagnostic confirmation was obtained in 2 (4.76%) cases which were low grade lesions (CIN 1). Only one patient had a positive serology. Among these treated women, 28 (66.66%) were lost to follow-up. At one month after treatment, 9 (64.2%) women had completely healed.

Conclusion: Precancerous cervical lesions are real and remain a public health problem in sexually active women. Regular screening and early management by treatment methods including thermocoagulation would prevent progression to cervical cancer.